000			01934 a2200565 4500
005			20250513145010.0
264		0	_c19980724
008			199807s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm980179c _2doi
040			_aNLM _beng _cNLM
100	1		_aAlbright, J D
245	0	0	_a5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors. _h[electronic resource]
260			_bJournal of medicinal chemistry _cJul 1998
300			_a2442-4 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aArginine Vasopressin _xantagonists & inhibitors
650	0	4	_aAzepines _xadministration & dosage
650	0	4	_aBenzamides _xadministration & dosage
650	0	4	_aBlood Platelets _xmetabolism
650	0	4	_aBody Water _xmetabolism
650	0	4	_aCell Line
650	0	4	_aCell Membrane _xmetabolism
650	0	4	_aDogs
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aHumans
650	0	4	_aKidney _xmetabolism
650	0	4	_aLiver _xmetabolism
650	0	4	_aOsmolar Concentration
650	0	4	_aPyrroles
650	0	4	_aRats
650	0	4	_aReceptors, Vasopressin _xmetabolism
650	0	4	_aSodium _xblood
650	0	4	_aStructure-Activity Relationship
650	0	4	_aUrine _xchemistry
700	1		_aReich, M F
700	1		_aDelos Santos, E G
700	1		_aDusza, J P
700	1		_aSum, F W
700	1		_aVenkatesan, A M
700	1		_aCoupet, J
700	1		_aChan, P S
700	1		_aRu, X
700	1		_aMazandarani, H
700	1		_aBailey, T
773	0		_tJournal of medicinal chemistry _gvol. 41 _gno. 14 _gp. 2442-4
856	4	0	_uhttps://doi.org/10.1021/jm980179c _zAvailable from publisher's website
999			_c9617275 _d9617275